GLENMARK THERAPEUTICS INC., USA
Dead / Abandoned — Abandoned — failure to respond (as of 24 Jul 2023)
What this means for you
This application is over — abandoned 28 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97345574
- Mark type
- Stylized text
- Filed
- 04 Apr 2022
- Published for opposition
- 20 Sept 2022
- Abandoned
- 28 Jun 2023
- Attorney of record
- Maxim A. Voltchenko
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of pharmaceutical preparations and chemical preparations for pharmaceutical or medical purposes
Owner
- Glenmark Therapeutics Inc., USA, Mahwah, NJ, US
- Glenmark Therapeutics Inc., USA, Mahwah, NJ, US
Prior registrations
Prosecution history
- 25 Jul 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 24 Jul 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 24 Jul 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2023 — NON-FINAL ACTION E-MAILED
- 27 Mar 2023 — SU - NON-FINAL ACTION - WRITTEN
- 16 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jan 2023 — USE AMENDMENT FILED
- 16 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jan 2023 — TEAS STATEMENT OF USE RECEIVED
- 15 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Sept 2022 — PUBLISHED FOR OPPOSITION
- 31 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER